多伦多炎性肠病全球内镜报告得分在性结肠炎的临床价值
Xin-Yue Liu1, Zi-Bin Tian1, Li-Jun Zhang2
1Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong Province, China.
World journal of gastroenterology
|January 8, 2024
概括
多伦多炎性肠病全球内镜报告 (TIGER) 评分在评估性结肠炎 (UC) 严重程度和预测治疗需求方面表现有前途. 这种新的评分系统可能比UCEIS和MES等现有方法提供优势,以改善患者管理.
科学领域:
- 胃肠病学 胃肠病学
- 内镜检查的评估.
- 炎症性肠病 (IBD) 是一种炎症性肠病.
背景情况:
- 内镜评估对于诊断和管理性结肠炎 (UC) 是至关重要的.
- 已建立的评分系统,如UCEIS和MES存在,但新的TIGER评分对UC的临床实用性需要进一步研究.
研究的目的:
- 在性结肠炎 (UC) 中评估多伦多炎性肠病全球内镜报告 (TIGER) 评分的临床价值.
- 为了比较TIGER评分的表现与性结肠炎内镜重度指数 (UCEIS) 和梅奥内镜子评分 (MES).
主要方法:
- 对166名接受全结肠镜检查的UC患者进行了回顾性分析.
- 收集和分析内镜分数,实验室数据,临床信息,治疗细节和1年的再入院.
- 统计分析包括相关系数,ROC曲线和后勤回归.
主要成果:
- 泰格得分与UCEIS和MES有显著的相关性,并且有效地区分了轻度,中度和严重的UC.
- 比MES,TIGER和UCEIS得分与临床和实验室参数 (CRP,ESR,住院时间/成本) 的相关性更强.
- 与UCEIS和MES相比,TIGER在高级治疗和1年再录取方面表现出更好的可预测性;TIGER分数≥317预测了高级治疗.
结论:
- 在准确评估UC临床疾病严重程度方面,TIGER得分显示出与UCEIS和MES相比的潜在优势.
- 泰格得分可以增强治疗决策,并改善UC患者短期预后的预测.
- TIGER评分是临床疾病评估和引导性结肠炎治疗策略的宝贵工具.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
187
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
187
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
164
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
164
01:17Assessment of the Gastrointestinal System I: Subjective Data
199
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
199
01:30Inflammatory Bowel Disease II: Crohn's Disease
251
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
251
01:21Inflammatory Bowel Disease V: Surgical Management
147
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
147